Hongju Yan

Safety and efficacy of CD33-targeted CAR-NK cell therapy for relapsed/refractory AML: preclinical evaluation and phase I trial

Ruihao Huang, Xiaoqi Wang, Hongju Yan et al. · Experimental Hematology and Oncology · 2025 · 47 citations · Full text

Life Sciences, Immunology, Oncology +17

Sirolimus as Rescue Therapy for Refractory/Relapsed Immune Thrombocytopenia: Results of a Single-Center, Prospective, Single-Arm Study

Yimei Feng, Yunshuo Xiao, Hongju Yan et al. · Frontiers in Medicine · 2020 · 42 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +16

Off-the-Shelf CD33 CAR-NK Cell Therapy for Relapse/Refractory AML: First-in-Human, Phase I Trial

Ruihao Huang, Qin Wen, Xiaoqi Wang et al. · Blood · 2022 · 33 citations

Medicine, Immunology, Oncology +14